Acurx Pharmaceuticals (ACXP): CFO received 26K units

26K

Derivative units

Traded

Apr 20, 2026

Filed

Apr 22, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On March 9, 2026, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Acurx Pharmaceuticals, Inc. (the “Company”) approved, and the executive officers listed below voluntarily agreed to, reductions to their base salaries (the “Salary Reductions”) as part of broader leadership compensation alignment measures.”
2. Apr 15, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Acurx Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for Acurx Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACXP page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Acurx Pharmaceuticals

• SEC Form 4Jan 8, 2025
• SEC Form 4Jan 8, 2025
• SEC Form 4Jan 8, 2025
• SEC Form 4Jan 8, 2025
• SEC Form 4Jan 8, 2025
• SEC Form 4Jan 8, 2025

Everything OQRO holds on this company is on its ACXP page.